New guidance available on Forecasting and Demand Planning to streamline supply chain performance

New guidance available on Forecasting and Demand Planning to streamline supply chain performance

  • Home
  • News and Papers
  • New guidance available on Forecasting and Demand Planning to streamline supply chain performance

The Forecasting and Demand Planning (FDP) workstream has looked at the problems that cause biomanufacturers and their suppliers to under and over plan commercial biologic drug manufacturing demands. They have addressed these issues in a best practice guide titled: Forecasting and Supply Planning: A Best Practice Industry Guide.

This guide defines the participating biomanufacturers’ and suppliers’ perspectives of the industry’s current roadblocks, the best practices that need to be more widely adopted and the business case for change.

 

 

“This best practice guide is something that will serve as a baseline in the industry for forecasting and demand planning” says Cheryl Simmons, Senior Manager, AstraZeneca. “It will help a supplier or drug manufacturer recognise what is considered best practice in areas such as supplier relationship management or performance management. Furthermore, it will allow them to see what their current status is and what their future status should look like.”

In order to define, prioritize and measure improvement opportunities across the industry, a Forecasting and Supply Planning maturity assessment has been developed to go along with the Best Practice Guide. The maturity assessment will identify an organization’s status against industry norms and best practice. To test it the companies who have built it have all used the survey to see where they stand, and will use it to track their progress as they fully implement the guidance.

Dan Tropea, Director of Supply Chain, NewAge/AdvantaPure reflected that “Some of [the survey] was alarming in that there was a gap between what best-in-class is and what the reality is. However, where there is alarm, there is an opportunity. It is a challenge to the BPOG membership to improve.

“The survey results allow us to set new levels of collaboration with our external partners. Our strategic plans are now dedicated to help build relationships that incorporate some of the targets in the survey. Using the survey gap analysis helped AdvantaPure develop a different mind set regarding how to manage our customers’ demands.”

An assessment result will provide a blueprint of the strengths and weaknesses that an organization needs to address to elevate its forecasting and supply planning processes. A video explaining the intent and purpose of the maturity assessment is also available on the BioPhorom website resource page here.

Both the guide and the tool kit are available on the BioPhorum website here

For any questions or interest in participating in the maturity assessment please contact the workstream facilitator jannika@biophorum.com.

Contact address

BioPhorum
The Gridiron Building
One Pancras Square
London
N1C 4AG

Newsletter subscribe

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.



© 2019 Biophorum Operations Group · All Rights Reserved

Registered Address: 5 Westbrook Court · 2 Sharrow Vale Road · Sheffield · S11 8YZ

Company Number 06794795 · VAT Number GB298617544

How the fast-start C&GT Phorum is delivering results

From a standing start in 2018, the BioPhorum Cell & Gene Therapy (C>) Phorum has made huge progress on a range of initiatives aimed at[...]

Read More
Driving progress in Cell & Gene Therapy

Now with 19 member companies and 183 subject matter experts, the BioPhorum Cell & Gene Therapy (C>) Phorum has made great strides since its formation[...]

Read More
Cell and Gene Therapy Phorum accelerates progress

The BioPhorum Cell & Gene Therapy Phorum has made significant progress since its creation in 2018 – from building networks and sharing knowledge to endorsing[...]

Read More
Sharing powerful collaboration data on the impact of resin cycling on viral clearance

A crucial issue for biotechnology products is that the mammalian cell lines commonly used in manufacturing are susceptible to viral contamination. Therefore, demonstration of viral[...]

Read More
Industry bioassay approach helps to shape the future

In 2018, members of the Development Group Bioassay workstream came together to write a best practices paper on bioassay development. We are delighted to announce[...]

Read More
Sharing ideas on forced degradation

“Forced degradation studies are an important part of the drug lifecycle process as they can inform many aspects of drug development,” said Jennifer Halley, Principal[...]

Read More
BioPhorum Anvisa support goes from strength to strength

There are many things that make a relationship work, such as trust, honesty and mutual respect. And a sign of a strong relationship is someone[...]

Read More
Delivering globally on in-line monitoring and real-time release

BioPhorum is increasing its focus on delivering against strategic goals of member companies as outlined in the BioPhorum Biomanufacturing Technology Roadmap. The first step in[...]

Read More
New and improved User Requirements Toolkit for single-use systems

To help customers and manufacturers achieve a ‘right first time’ implementation of single-use systems, BioPhorum launched a User Requirements Toolkit in June 2018. This includes[...]

Read More
PUPSIT – An update on BioPhorum/PDA work to develop a risk-based position
Read More
Driving the evolution of secondary packaging

How do we transition from large-batch manufacture to small-batch, high-value packaging runs?

Read More
Hi-tech ambitions for Fill Finish

The Fill Finish Phorum has recently embarked on a series of exciting and ambitious initiatives, exploring new technologies and processes to enhance the efficiency and[...]

Read More
Logistics collaboration hub: An opportunity for significant time and cost savings

Most biopharmaceutical manufacturers use a network of logistics service providers (LSPs) to deliver warehousing, transport and distribution services, and they are usually linked using customized,[...]

Read More
The ‘how to’ guide to implementing Agile in GxP

The publication of the Guidance on the use of Agile in a GxP Environment document in 2017 was well received.It described how the use of[...]

Read More
How smart is your maintenance?

Faster. Cheaper. Smarter. All companies are under pressure to achieve more with less, not least with their maintenance programs. But while ‘faster’ and ‘cheaper’ maintenance[...]

Read More
BioPhorum’s Maturity Assessment Tool gains momentum
Read More
Supply chain, forecasting and demand planning solutions gain momentum

The relationship between suppliers and manufacturers is one of the most crucial in biopharmaceutical manufacturing. This is especially the case when forecasting and supply planning.[...]

Read More
2018 highlights

BioPhorum’s mission has always been to make the journey for tackling industry challenges better, faster and cheaper for members. By helping you to work on[...]

Read More
BioPhorum blazes a trail tackling your buffer preparation bottlenecks

Buffers are critical inputs into all downstream processing steps associated with the manufacture of therapeutic proteins. The large volumes of buffer required present ongoing logistical[...]

Read More
How plug-and-play will help you glide through the biomanufacturing dance

It is pretty clear that automation can improve efficiency, track performance and liberate operators from mundane routines. But with it comes cost and time factors[...]

Read More
Delivering globally on in-line monitoring and real-time release

BioPhorum is increasing its focus on delivering against strategic goals of member companies as outlined in the BioPhorum Biomanufacturing Technology Roadmap. The first step in[...]

Read More
Slicing years off change implementation

As the first regulatory authority in Latin America to gain full membership of the International Council for Harmonization (ICH), the Brazilian Health Regulatory Agency (Anvisa)[...]

Read More
BioPhorum Regulatory Interaction: helping to open doors

To implement any change in the biopharmaceutical manufacturing industry it is important to engage with and collaborate with the regulators. Set up two years ago,[...]

Read More
Regulatory compliance: what lessons can be learned?

BioPhorum delivery of value from the disposables five-year plan - supplier change notifications for single-use systems

Read More
Navigating the maze of medical technology regulation: a solo voyage or a team effort?

Medical technology is a global business, generating annual revenues of over $400bn. The sector encompasses a broad range of technologies: from in-vitro diagnostics and diagnostic[...]

Read More

IaaS Cloud webinar recording play back
Read More
New BPIT guidance to align cloud services to regulatory requirements
Read More
Data Integrity and Agile Webinars to support industry response to regulators
Read More
How to validate informatics in CPV programs

The BioPhorum Continued Process Verification (CPV) and Informatics team has published a paper to support a risk-based approach for the validation of informatics systems for[...]

Read More
Continued Process Verification delivering real saving in time and money

More than 50 per cent of biopharma products on the market now have Continued Process Verification (CPV) plans in place.  Thanks to the CPV white[...]

Read More
A roadmap for the implementation of continued process verification

This article provides a roadmap draws on the content of the CPV case study to provide a step-by-step guide in a more accessible form.

Read More
How smart is your maintenance?

Faster. Cheaper. Smarter. All companies are under pressure to achieve more with less, not least with their maintenance programs. But while ‘faster’ and ‘cheaper’ maintenance[...]

Read More
Digital plant maturity model webinar replay
Read More
Digital Plant Maturity Model workstream to host webinar
Read More
New guidance available on Forecasting and Demand Planning to streamline supply chain performance
Read More
Changes to BioPhorum extractables protocol

The BioPhorum Extractables team has shown the benefits of great collaboration between biomanufacturers and suppliers – they agreed to significantly reduce extractables testing for single use[...]

Read More
Host cell proteins poster

This poster presented at the BEBPA Conference, San Francisco builds and consolidates the information currently available in the industry for assessing process risk from Host[...]

Read More
Host cell protein risk assessment, an industry approach

Host cell protein (HCP) constitutes a significant class of process-related impurities in biological drugs.

Read More
BEBPA risk assessment workshop
Read More
New and improved User Requirements Toolkit for single-use systems

To help customers and manufacturers achieve a ‘right first time’ implementation of single-use systems, BioPhorum launched a User Requirements Toolkit in June 2018. This includes[...]

Read More
BioPhorum blazes a trail tackling your buffer preparation bottlenecks

Buffers are critical inputs into all downstream processing steps associated with the manufacture of therapeutic proteins. The large volumes of buffer required present ongoing logistical[...]

Read More
How plug-and-play will help you glide through the biomanufacturing dance

It is pretty clear that automation can improve efficiency, track performance and liberate operators from mundane routines. But with it comes cost and time factors[...]

Read More
BioPhorum Anvisa support goes from strength to strength

There are many things that make a relationship work, such as trust, honesty and mutual respect. And a sign of a strong relationship is someone[...]

Read More

Share This

Share this

Share this post with your colleagues.